Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Lenalidomide

An immunomodulatory analogue of thalidomide, approved in the United States in 2005 for some myelodysplastic syndromes: it is also used in multiple myeloma and some lymphomas. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?It acts as a 'molecular glue': it binds the protein cereblon and makes it tag Ikaros and Aiolos, two factors myeloma cells cannot do without, for destruction. The mechanism was worked out in 2013-2014.

LenalidomideGo to the active ingredient →
LenalidomideActive ingredientLenalidomideCat. No. P-L033-001CAS 191732-72-6

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.